Paloma Partners’s Sotera Health SHC Stock Holding History

Paloma Partners’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,645	Closed	-$241K	–	2220
2021 Q1	$241K	Buy	+9,645	New	+$255K	0.01%	1655

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Paloma Partners's SHC Position: Q2 2021 in Review

Paloma Partners sold out of Sotera Health (SHC) in Q2 2021, closing a stake of 9,645 shares — an estimated $241K sold.

Paloma Partners first reported a position in SHC in Q1 2021 and held it in 1 quarter. The position peaked at $241K in Q1 2021. 133 funds tracked by Wall St. Rank hold SHC as of Q2 2021.

Paloma Partners reported no remaining Sotera Health position as of Q2 2021 after selling out during the quarter.
Paloma Partners sold 9,645 Sotera Health shares in Q2 2021, an estimated $241K.
Paloma Partners first reported a position in Sotera Health in Q1 2021 and held it in 1 quarter.
Paloma Partners's Sotera Health position peaked at $241K in Q1 2021.
133 funds tracked by Wall St. Rank held Sotera Health as of Q2 2021.

Based on Paloma Partners's 13F filing for Q2 2021, filed 16 Aug 2021.